Use of renin-angiotensin inhibitors in people with renal artery stenosis.

ABSTRACT:

Background and objectives

People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers, but little is known about the factors associated with their use.

Design, setting, participants, & measurements

The Cardiovascular Outcomes in Renal Atherosclerotic Lesions study (ClinicalTrials.gov identified: NCT00081731) is a prospective, international, multicenter clinical trial that randomly assigned participants with atherosclerotic renal artery stenosis who received optimal medical therapy to stenting versus no stenting from May 2005 through January 2010. At baseline, medication information was available from 853 of 931 randomly assigned participants. Kidney function was m

SUBMITTER: Evans KL 

PROVIDER: S-EPMC4078968 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature